Showing results (2321-2330 of 2,892) with videos related to

Sort By:
Pageof 290
Circulation. Cardiovascular Quality and Outcomes|February 21, 2025
Variations in the Medical Device Authorization and Reimbursement Landscape: A Case Study of 2 Cardiovascular Devices Across 4 CountriesMarta M Williams, Nathan R Smith, Carin A Uyl-de Groot, et al.
The Oncologist|March 9, 2021
A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial ExperienceChantal Pauli, Tilmann Bochtler, Linda Mileshkin, et al.
The American Journal of Dermatopathology|January 4, 2017
Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic MelanomaJ Andrew Carlson, Jose Candido Caldeira Xavier, Ashley Tarasen, et al.
JCO Precision Oncology|July 6, 2023
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor EffectivenessJulia C F Quintanilha, Michael H Storandt, Ryon P Graf, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 3, 2020
Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutationsErik A Williams, Meagan Montesion, Nikunj Shah, et al.
The Oncologist|September 30, 2016
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal CancerAndrew Rankin, Samuel J Klempner, Rachel Erlich, et al.
Breast Cancer Research and Treatment|October 14, 2015
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterationsJeffrey S Ross, Siraj M Ali, Kai Wang, et al.
Case Reports in Oncology|September 19, 2014
Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown PrimaryNorma A Palma, Siraj M Ali, Jamie O'Connor, et al.
Circulation. Heart Failure|November 12, 2009
Recent national trends in readmission rates after heart failure hospitalizationJoseph S Ross, Jersey Chen, Zhenqiu Lin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2016
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CTGary A Ulaner, David M Hyman, Dara S Ross, et al.
Pageof 290